Application of the Euro Clonality next-generation sequencing-based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial.

Publication Year: 2021

DOI:
10.1111/bjh.17519

PMCID:
PMC8515379

PMID:
34002365

Journal Information

Full Title: Br J Haematol

Abbreviation: Br J Haematol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest The authors declare to have no potential conflicts of interest regarding the present work."

Evidence found in paper:

"This work was supported by: Fondi di Ricerca Locale, Università degli Studi di Torino, Italy; Fondazione CRT (projects code: 2016.0677, 2018.1284), Torino, Italy; Gilead Fellowship Program 2019, Milano, Italy; Cancer Research UK (C355/A26819) and FC AECC and AIRC under the Accelerator Award Program. We are grateful to the EuroClonality‐NGS Working Group (coordinated by Anton W Langerak) and to the University of Kiel (Christiane Pott, Monika Brüggemann, Henrik Knecht and Dietrich Hermann) for discussion of ideas and results which has helped writing our manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025